RWE-based Treatment Patterns and Outcomes in CIDP
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy; Guillain-Barre Syndrome; Hereditary Amyloidosis Intervention: Other: No intervention. Retrospective observation only. Sponsors: RwHealth; Alnylam Pharmaceuticals; Northern Care Alliance NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials